Background-Increasingly, the diagnostic codes from administrative claims data are being used as clinical outcomes. Methods and Results-Data from the Cardiovascular Health Study (CHS) were used to compare event rates and risk factor associations between adjudicated hospitalized cardiovascular events and claims-based methods of defining events. The outcomes of myocardial infarction (MI), stroke, and heart failure were defined in 3 ways: the CHS adjudicated event Key Words: epidemiology ◼ heart failure ◼ incidence ◼ myocardial infarction ◼ stroke © 2015 American Heart Association, Inc.
I ncreasingly, the diagnostic codes from administrative claims data are being used as clinical outcomes in epidemiological studies. Since 1983 at the Center for Medicare and Medicaid Services (CMS), the principal or primary diagnosis of a hospitalization has been used to determine the diagnosis-related group for reimbursement. 1 Over time, changes in the reimbursement practices have tended to influence coding patterns. For instance, the 2007 implementation of medical-severity diagnosis-related group codes was associated with a decrease in the hospitalization rate for essential hypertension and an increase in the rate for malignant hypertension. This pattern of coding increased reimbursement to hospitals, and the fact that the mortality rate for malignant hypertension dropped significantly after 2007 suggests that the observed changes in these hospitalization rates were likely the result of trends in coding practices rather than changes in disease prevalence, severity, or treatment. 2 In other words, administrative claims data serve a dual role, the electronic side effects of both clinical care and reimbursement policies.
Clinical Perspective on p 164
Typically, the validity of the diagnostic codes from claims data has been evaluated in terms of their positive predictive value (PPV) in small samples. 3, 4 A high PPV means that a large proportion of cases identified by selected diagnostic codes meet study criteria for an event. In-patient diagnostic codes for many common cardiovascular diseases (CVDs), including myocardial infarction (MI), heart failure (HF), and stroke, have high PPVs, [5] [6] [7] and these codes are often used without further review as primary outcomes. Of course, hospitalization data fail to detect outpatient events and out-of-hospital deaths. Nevertheless, diagnostic codes from administrative hospitalization claims are now so commonly used as clinical end points that new conventional definitions are beginning to emerge in the published literature. For HF and stroke, selected diagnostic codes as the primary reason for hospitalization, the principal diagnosis, often count as events, but the same diagnostic codes in other secondary positions do not count as events. [8] [9] [10] For MI, although some studies use the International Classification of Diseases, Ninth Edition (ICD-9) code 410 only in the primary position to define events, 3, 9 others accept an ICD-9 code 410 in any position as the definition of an event. 8, 10, 11 In both observational studies and clinical trials, CVD event rates vary for a number of biological and methodological reasons. The observed event rate in a study depends not only on the population under study but also on the methods of case identification, the intensity of the surveillance efforts, the aggressiveness of data collection, the criteria for validating events, and the quality control of the overall effort. Such labor-intensive efforts often involve physician review of medical records. [12] [13] [14] [15] One consequence of active-surveillance methods is the assembly of genuine events that reduce the bias from misclassification. The claims-based methods that use a combination of diagnostic codes and positions with high PPVs are also intended to reduce misclassification. The other consequence of active-surveillance methods is the complete or near-complete identification of clinical outcomes in a study. When the emerging conventions used to define clinical CVD outcomes in claims-based analyses intentionally ignore low-PPV diagnostic codes that are known to harbor some genuine events, they systematically underestimate event rates and the absolute levels of risk. In this analysis of events data from the Cardiovascular Health Study (CHS), we evaluate the degree of both the misclassification and the underestimation of event rates for CVD outcomes identified solely from claims data compared with those identified through CHS active-surveillance procedures.
Methods

Design
CHS is a cohort study designed to evaluate risk factors for coronary heart disease and stroke in older adults. 16 At the 4 field centers, each community sample was obtained from random samples of the Medicare lists. Eligible to participate were people living in the household of each sampled individual who were ≥65 years of age, noninstitutionalized, expected to remain in the area for 3 years, and able to give informed consent. In 1989 to 1990, the field centers recruited 5201 participants. In 1992 to 1993, an additional 687 blacks were recruited with the use of similar methods. The baseline examinations consisted of a home interview and a clinic examination that assessed traditional risk factors such as blood pressure, weight, height, smoking status, and medication use 17 ; a fasting blood specimen for glucose and lipids; and measures of subclinical disease, including carotid ultrasound, echocardiography, electrocardiography, and pulmonary function. Participants were eligible for CHS regardless of whether they had had prevalent CVD at baseline. Baseline reports of prevalent disease were validated. 18 Semiannual participant contacts to obtain information about potential events alternated between a telephone interview and an annual clinic examination until 1998 to 1999.
Since 2000, participants or their proxies have been contacted every 6 months for this information. The study was approved by institutional review committees at the participating sites, and all participants provided written informed consent.
Primary and Secondary Outcomes
CHS events criteria for MI, stroke, and HF have been published. 12, [19] [20] [21] For MI, they include the traditional elements of chest pain, cardiac enzymes, and ECGs. Criteria for HF rely on physician diagnosis, treatment, and diagnostic test results. 12 Stroke is defined as a clinical event of rapid onset consisting of a focal neurological deficit lasting >24 hours unless death supervenes. 19, 21 As a result of a broad interest in a variety of health conditions that affect older adults, the goal of the events data collection was not only to ascertain incident cardiovascular events but also to create a database of all hospitalizations that included discharge diagnoses, procedures, and at least a discharge summary. This research resource was designed so that other events such as venous thromboembolism, 22 hip fracture, 23 and pneumonia 24 could be captured and studied more easily.
Methods of Events Identification, Data Collection, and Adjudication
Between the 6-month contacts to obtain information about cardiovascular events and all hospitalizations, participants and their proxies were asked to call the field center to report them. Field center investigations for all hospitalizations occasionally identified other unreported hospitalizations. Periodically, CHS also used Medicare data to identify hospitalizations that may have been missed by self-report. Deaths were identified from proxies on follow-up calls, searches in the local obituaries, and periodic searches of the National Death Index. A broad set of diagnostic codes was used to identify potential events. 12, 19 Additionally, field center review of the discharge diagnoses and the text of the discharge summaries of all hospitalizations was used to identify other potential clinical CVD outcomes that had not been self-reported. The initial report form indicated how the event was first identified. The events data collected for adjudication were matched to the events criteria and included (when appropriate or available) hospital records and outpatient medical records; copies of ECGs, head computed tomography, and magnetic resonance imaging scans; results of diagnostic tests; questionnaires for physicians caring for participants; death certificates, autopsy reports, and coroner reports; and an interview with proxies or witnesses for all out-of-hospital deaths. The data from potential events identified by all methods were reviewed and classified by physician members of the Stroke and Cardiac Events Committees. Adjudicators were blinded to baseline risk factor data. Each potential CVD event of any type, MI, angina, HF, and peripheral arterial disease, was reviewed for all cardiac event types. During each meeting, a sample of events was included for blinded rereview as a quality-control effort. The agreement between reviews for nonfatal events has been excellent, with κ values of 0.86 (95% confidence interval, 0.78-0.93; n=241) for MI, 0.87 (95% confidence interval, 0.75-0.99; n=62) for stroke, and 0.85 (95% confidence interval, 0.78-0.92; n= 241) for HF.
Analysis
CHS participants were sampled from Medicare lists, and CMS Part A data were obtained for all Medicare fee-for-service beneficiaries through December 2012. In addition, CHS conducted surveillance activities and identified incident events and hospitalizations for Medicare beneficiaries enrolled in managed care plans and for those treated at Veterans Administration Hospitals. Discharge summaries from the hospitalized events were obtained so that the CHS hospitalization database would include discharge diagnoses for all participants. Because this CHS active surveillance provided information on the CMS non-fee-for-service hospitalizations, we were able to include all participants and all available follow-up time in the analysis. 25 to estimate whether the point estimates for risk factor associations with the ICD-9 code-based definitions were statistically significantly different from the point estimate for the same risk factor associations with the adjudicated events. Insofar as misclassified events lack any association with the risk factors of interest, risk estimates for an outcome that includes misclassified events will typically be biased toward the null. In this study, all CMS events were hospitalizations; as a result, a misclassified CMS MI represents an illness requiring a hospitalization for another reason. To determine the extent to which CVD risk factors were associated with hospitalization in general and not specifically with an MI hospitalization, we also evaluated the association between traditional CVD risk factors and all first hospitalizations not resulting from an MI. Statistical analysis and data management were performed with SAS version 9.1.4; forest plots were performed with STATA.
Results
Based on information from initial report forms, Table 1 summarizes how the 28 230 hospitalizations for the 5888 CHS participants were first identified in CHS. Of the 4344 incident cardiovascular events, for instance, 59.0% were first identified by self-report, 29.2% by field center investigation, 3.5% by periodic searches of Medicare data, and 8.4% by a method that was not recorded on the initial report form. The percentages of events identified by self-report were generally similar across types of clinical outcomes, ranging from 57.0% for stroke to 66.3% for angina.
Studies that rely on diagnostic codes from claims data as outcomes use selected codes and their diagnostic positions to define events. With the CHS[adj] results serving as the standard, Table 2 shows the PPVs and the proportions of events identified by commonly used CMS conventions for clinical outcomes. For MI, the PPV of ICD-9 code 410 in the first position was 90.6%, but this code identified only 53.8% of incident MIs ascertained by active surveillance in CHS. Code 410 as any secondary diagnosis identified an additional 16.6% of MI events with a PPV of 69.8%. For all the other ischemic heart disease codes, the PPVs were low, but because they made up so many hospitalizations, they accounted for 29.6% of all incident MI events. For the main stroke codes in the first position, the emerging convention for stroke in the literature, the PPV was 80.4%, but it was only 44.4% in the second position. Strokes ascertained by the main codes as primary diagnoses in claims data identified only 63.8% of the incident stroke events. For HF, the main diagnostic codes in the primary position had a high PPV of 93.2% but identified only 27.2% of HF events. (Table II in the online-only Data Supplement includes the results for HF stratified by ejection fraction.)
For the CVD events that lacked qualifying disease codes, we ascertained the primary reason for hospitalization. For MI, the most common were other forms of ischemic heart disease (n=57 of 284); HF (n=44); arrhythmia, primarily atrial fibrillation (n=21); pneumonia (n=20); and cerebrovascular disease (n=12). For stroke, they were other forms of cerebrovascular disease (n=36 of 212), ischemic heart disease (n=21), arrhythmia (n= 13), symptoms such as altered consciousness or coma (n=10), HF (n=8), and femur fracture (n=8). For HF, they were ischemic heart disease (n= 58 of 293), arrhythmia (n=22), pneumonia (n=27), respiratory and chest symptoms (n=12), and rheumatic or valvular heart disease (n=11).
Estimates of disease incidence differed markedly across the 3 methods for identifying events. For CHS [adj] , CMS[1st], and CMS[any], the incidence rates per 1000 person-years by age category are displayed for MI in Figure 1A , stroke in Figure 1B , and HF in Figure 1C . In Figure 1A , for instance, the MI incidence increased with age, although there were only 29 events among those ≥85 years of age. For MI, the For each of the 3 incident events, the association analyses were designed to compare risk factor associations across the 3 methods of defining each event type. For all outcomes, Figure 2 shows that the risk factor associations were generally similar across the 3 methods of events identification, perhaps with some minor differences. (Numeric values for hazard ratios and confidence intervals are given in Table III in the onlineonly Data Supplement.) For MI, the CMS[any] association was significantly lower for black race but significantly higher for total cholesterol, elevated fasting glucose, and drug-treated diabetes mellitus. For stroke, CMS[any] association was significantly higher for men and for smoking. For HF, CMS[any] HF associations were significantly stronger for age and weaker for drug-treated diabetes mellitus. In general, the misclassified events in the CMS analyses appeared to have little effect on the magnitude of associations for most of the CVD risk factors.
Many traditional CVD risk factors are nonspecific and associated with conditions that lead to hospitalization. Table IV in the online-only Data Supplement.)
With the exception of lipids, CVD risk factors were associated with a first non-MI hospitalization. Many of the hazard ratios were similar in magnitude to those for incident MI, and the point estimates for smoking and drug-treated hypertension were larger for non-MI hospitalization than for incident MI.
In sensitivity analyses, the results changed only in trivial ways when we restricted the analysis to fee-for-service beneficiaries, when we restricted the analysis only to definite events, and when we looked at time trends, that is, before and after January 1, 1999 (Table V in the online-only Data Supplement).
Discussion
For MI, stroke, and HF, we compared adjudicated events with 2 claims-based approaches to defining health end points in terms of event rates and risk factor associations. The multiple methods used for the active surveillance in CHS improved the completeness of events identification (Table 1) . Conventional claims-based methods of defining events, especially those for stroke and HF, which use only the principal diagnosis, had high PPVs, but these methods intentionally ignore genuine events that appear in low-PPV diagnostic codes and positions ( Table 2) . As a result, the event rates based on the emerging conventions for claims-based methods for CMS [ (Figure 1 ). In general, CVD risk factor associations were similar across the 3 methods of defining events for MI, stroke, and HF (Figure 2) . Indeed, most CVD risk factors were also associated with the risk of a first non-MI hospitalization (Figure 3) . Event rates are directly related to the intensity of surveillance. Like the Framingham Heart Study (FHS) and the Atherosclerosis Risk in Communities (ARIC) Study, 13, 14, 26 CHS is an active-surveillance study. In an effort to develop a research resource for a variety of health outcomes, CHS used multiple methods, including CMS data, to identify potential events. In this setting, self-report alone identified only 61.7% of incident events. Similar findings have been reported by other studies. 15, 27 Although some events were surely missed in CHS, the consequence of broad surveillance efforts is likely to be near-complete identification of key cardiovascular events.
Criteria for a diagnosis of MI, stroke, and HF may vary across studies and clinical settings. Nonetheless, claimsbased definitions of CVD events have often worked well, 11 and in a previous publication, the mortality rates of participants with incident HF events identified by both CHS and ICD-9 codes were slightly higher than the mortality rates of those identified by either method alone. 28 The validity of claims-based diagnostic codes also depends importantly on the condition. For instance, administrative data alone, without review of the medical records, do not work well for specialized studies of drug-induced liver injury 29 or statinrelated rhabdomyolysis. 30 On October 1, 2015, the 10th revision of the ICD was implemented in the United States, and although the diagnostic performance of the new codes is likely to be similar to that of the old codes, continued vigilance is warranted.
In association analyses, nondifferential misclassification generally drives associations toward the null, and the effects of large levels of misclassification can be pronounced. 30 For MI, stroke, and HF, however, the high PPVs of the claimbased methods, particularly those that use the principal diagnosis, tend to minimize the potential for bias from misclassification. With information on sensitivity and specificity, methods of quantitative bias analysis can characterize plausible effects of outcome misclassification bias on estimated associations. [31] [32] [33] These methods all assume, however, that the misclassified event has no association with the risk factors of interest. The use of selected diagnostic codes from hospitalizations as events means that even a misclassified event involves a serious health condition that required hospitalization. In effect, claims-based events data represent a composite end point that includes both the outcome of interest and selected (misclassified) nonevent hospitalizations. As illustrated in Figure 3 , the hazard ratios for all first hospitalizations not resulting from an MI suggest that hospitalizations randomly misclassified as MIs would have little effect on the strength of associations of MI with a number of CVD risk factors. Under these circumstances, showing that the levels of risk factor associations for an outcome are consistent with the published literature 34 may in fact provide little evidence of validity. For other less promiscuous risk factors or exposures, the effect of misclassification may be more pronounced.
The use of claims-based methods with high PPVs to define events comes at the price of low sensitivity. For MI and stroke, the conventional claims-based methods identified only about two thirds of the events in CHS (Table 2 ). In some settings such as the Mini-Sentinel with 178 million covered lives, 35 the available sample size is so large or the marginal cost of study power depends importantly on the observed event rates: To achieve comparable power, the efforts to recruit and examine additional patients may be much more costly than the efforts to improve the ascertainment of the primary events of interest. By design, events data collection methods should be efficient and fit for purpose. Observed event rates depend importantly on the intensity of identification and investigation. As a result, active-surveillance studies generate higher estimates of event rates than studies that rely on self-report. When data from active-surveillance studies are used to create risk-prediction algorithms, they also generate higher levels of predicted absolute risk. Data from CHS, FHS, and ARIC, all active-surveillance studies, were used to develop the risk calculator 39 for the Adult Treatment Panel IV guidelines for lipids. 40 Although the new guidelines were controversial for a number of reasons, a persistent complaint was the apparent overestimation of the absolute risk produced by the calculator compared with studies that had used self-report to identify events. 41, 42 Missed events in studies that rely on selfreport for the ascertainment of outcomes remain a cogent alternative explanation for large differences in the absolute event rates. As demonstrated by the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, 43 additional data from CMS substantially reduced the perceived overestimation in risk associated with events identified by self report.
For studies in which the use of high-PPV codes is not suspected to introduce bias, the underestimation of event rates may not be a concern. However, for studies in which power is at a premium, bias must be minimized, or accurate estimates of incidence are of interest, the use of highquality surveillance methods has much to recommend itself. Although events data collection activities should be appropriate to the purpose of the study, the achieved or observed event rates in both observational studies and clinical trials can also serve as an important quality-control measure of study conduct.
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CLINICAL PERSPECTIvE
In both observational studies and clinical trials, cardiovascular disease event rates vary for a number of biological and methodological reasons. Increasingly, the diagnostic codes from administrative claims data are being used to measure clinical outcomes. The quality of claims data varies according to the condition, and many cardiovascular events are coded with a moderate degree of accuracy. The approach of defining events on the basis of claims data influences the results. Methods that minimize misclassification such as the use of specific diagnostic codes in the primary diagnosis position also tend to underestimate event rates. Methods that use broad diagnostic codes in any position tend to capture not only genuine outcomes of interest but also nonevents that fail to meet standard criteria. Levels of risk factor associations with the outcome may not be reliable guides to the amount of misclassification. Observed event rates are directly related to the intensity of surveillance. When data from active-surveillance studies are used, for instance, to create risk-prediction algorithms, they also generate higher levels of predicted absolute risk than studies that rely on passive surveillance or self-report. Although events data collection activities should be appropriate to the purpose of the study, the achieved or observed event rates in both observational studies and clinical trials can also serve as an important quality-control measure of study conduct. 
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